Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(3.16) per share which beat the analyst consensus estimate of $(4.40) by 28.18 percent. This is a 27.52 percent increase over losses of $(4.36) per share from the same period last year.
Posted In: KALA